Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |